D-glutamic acid for UV-induced skin damage prevention

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional prophylactic and therapeutic agents for ultraviolet irradiation-induced skin damage are not routinely usable, stable, or safe, and primarily offer symptomatic relief, lacking effective prevention and treatment options for UV-induced skin conditions and cataracts.

Innovation Solution

Administration of D-glutamic acid and its salts, which can be incorporated into cosmetic, pharmaceutical, or food compositions, to provide a stable and safe solution for preventing or treating ultraviolet irradiation-induced skin damage, including wrinkles and cataracts, by alleviating UV-induced cell damage in keratinocytes and fibroblasts.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional ultraviolet scattering agents or absorbers are used for preventing sunburn, then ultraviolet protection is achieved, but routine usability is reduced due to stability and safety issues

Engineering Contradiction:
Improvestability and safetyVSAvoidroutine usability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The invention changes the chemical parameter from conventional ultraviolet scattering agents (titanium oxide) or absorbers (ethyl hexyl p-methoxycinnamic acid) to D-glutamic acid, which provides both superior stability and safety profiles, enabling routine daily use without the limitations of previous agents

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

D-glutamic acid offers a cost-effective alternative to conventional UV protection agents, providing stable and safe protection that can be used routinely without the stability concerns that limit the use of other agents

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Reliability

If conventional therapeutic agents are used for ultraviolet irradiation-induced skin damage, then symptomatic relief is provided, but effective prevention and treatment of underlying damage is lacking

Engineering Contradiction:
Improveeffectiveness of prevention and treatmentVSAvoidsymptomatic relief only
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

D-glutamic acid is applied before ultraviolet irradiation to prevent skin damage from occurring in the first place, rather than merely treating symptoms after damage has occurred. This preliminary protective action addresses the root cause by enhancing cellular resistance to UV-induced stress

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

D-glutamic acid acts as a biochemical intermediary that mediates between ultraviolet radiation and skin cells, protecting keratinocytes and fibroblasts from damage through its antioxidant and cytoprotective properties, thereby preventing both immediate and long-term damage

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

D-glutamic acid effectively alleviates ultraviolet irradiation-induced cell damage in a concentration-dependent manner, offering a novel and stable solution for routine use in preventing or treating UV-induced skin conditions and cataracts, as demonstrated by its ability to increase fluorescent intensity and reduce cell damage in human keratinocyte and fibroblast cultures.

Implementation Method 1

an antioxidant which removes a free radical generated by the ultraviolet

Methodology Applied
Scientific EffectAntioxidant activity: Oxidation

Data Source

PatentEP2415468B1D-glutamic acid for alleviating ultraviolet radiation-induced damage
Publication Date: 2017.07.05 SHISEIDO CO LTD
  • EP2415468B1 patent drawingFigure 1~2
  • EP2415468B1 patent drawingFigure 3~4
  • EP2415468B1 patent drawingFigure 5~6

AI summary

Disclosed are: a composition for alleviating ultraviolet irradiation-induced damage, which can be used on a daily based and is stable and safe; and a pharmaceutical preparation, a cosmetic and a food composition, each of which comprises the composition. The composition for alleviating ultraviolet irradiation-induced damage contains one or more compounds selected from the group consisting of D-glutamic acid, L-glutamic acid, D-proline, D-cystine, L-cystine, and derivatives and/or salts of the aforementioned compounds. The composition can be used as an external formulation for the skin, a cosmetic composition, an anti-wrinkle agent, a sunscreen agent, a pharmaceutical composition for treating and/or preventing skin diseases, a food composition, or a pharmaceutical composition for preventing or treating cataract.